Brian C Callaghan, Ranjit Mohan Anjana, Lavanya Muthukumar, Evan L Reynolds, Jebarani Saravanan, Mani Arun Vignesh, Aswin Mukundan, Eva L Feldman, Viswanathan Mohan
{"title":"Severe insulin-deficient diabetes is at the opposite end of the neuropathy spectrum to mild aged-related diabetes","authors":"Brian C Callaghan, Ranjit Mohan Anjana, Lavanya Muthukumar, Evan L Reynolds, Jebarani Saravanan, Mani Arun Vignesh, Aswin Mukundan, Eva L Feldman, Viswanathan Mohan","doi":"10.1111/jdi.70033","DOIUrl":null,"url":null,"abstract":"<p>The effect of diabetes subtypes on neuropathy prevalence and metabolic drivers of this relationship are unknown. Using electronic medical records from 50 diabetes care centers in eight states of India with biothesiometer and complete phenotyping data on 22,348 patients, we determined neuropathy prevalence stratified by India-specific diabetes subtypes and evaluated associations with neuropathy (biothesiometer). Neuropathy prevalence was highest in severe insulin-deficient diabetes (SIDD; 25.5%), followed by insulin-resistant obese diabetes (IROD; 21.8%), mild age-related diabetes (MARD; 18.9%), and combined insulin-resistant and deficient diabetes (CIRDD; 17.3%, <i>P</i> = <0.001). HbA1c (odds ratio [OR]: 1.19, 1.16–1.21), diabetes duration (OR: 1.04, 1.04–1.05), and waist circumference (OR: 1.01, 1.01–1.02) were associated with neuropathy. SIDD (OR: 2.23, 2.01–2.47), CIRDD (OR: 1.89, 1.69–2.11), and IROD (OR: 1.84, 1.66–2.04) had increased neuropathy compared to MARD. In India, SIDD patients are more likely to have neuropathy compared to MARD patients likely from longer diabetes duration and higher HbA1c; therefore, interventions should focus on hyperglycemia. Interventions in CIRDD and IROD patients should likely address obesity as well.</p>","PeriodicalId":51250,"journal":{"name":"Journal of Diabetes Investigation","volume":"16 6","pages":"1045-1049"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.70033","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdi.70033","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
The effect of diabetes subtypes on neuropathy prevalence and metabolic drivers of this relationship are unknown. Using electronic medical records from 50 diabetes care centers in eight states of India with biothesiometer and complete phenotyping data on 22,348 patients, we determined neuropathy prevalence stratified by India-specific diabetes subtypes and evaluated associations with neuropathy (biothesiometer). Neuropathy prevalence was highest in severe insulin-deficient diabetes (SIDD; 25.5%), followed by insulin-resistant obese diabetes (IROD; 21.8%), mild age-related diabetes (MARD; 18.9%), and combined insulin-resistant and deficient diabetes (CIRDD; 17.3%, P = <0.001). HbA1c (odds ratio [OR]: 1.19, 1.16–1.21), diabetes duration (OR: 1.04, 1.04–1.05), and waist circumference (OR: 1.01, 1.01–1.02) were associated with neuropathy. SIDD (OR: 2.23, 2.01–2.47), CIRDD (OR: 1.89, 1.69–2.11), and IROD (OR: 1.84, 1.66–2.04) had increased neuropathy compared to MARD. In India, SIDD patients are more likely to have neuropathy compared to MARD patients likely from longer diabetes duration and higher HbA1c; therefore, interventions should focus on hyperglycemia. Interventions in CIRDD and IROD patients should likely address obesity as well.
糖尿病亚型对神经病变患病率的影响以及这种关系的代谢驱动因素尚不清楚。利用来自印度8个邦50个糖尿病护理中心的电子病历,以及22,348名患者的生物计量仪和完整的表型数据,我们确定了按印度特异性糖尿病亚型分层的神经病变患病率,并评估了与神经病变的关系(生物计量仪)。神经病变患病率最高的是严重胰岛素缺乏性糖尿病(SIDD;25.5%),其次是胰岛素抵抗型肥胖糖尿病(IROD;21.8%),轻度年龄相关性糖尿病(MARD;18.9%),以及合并胰岛素抵抗和缺陷型糖尿病(CIRDD;17.3%, p =
期刊介绍:
Journal of Diabetes Investigation is your core diabetes journal from Asia; the official journal of the Asian Association for the Study of Diabetes (AASD). The journal publishes original research, country reports, commentaries, reviews, mini-reviews, case reports, letters, as well as editorials and news. Embracing clinical and experimental research in diabetes and related areas, the Journal of Diabetes Investigation includes aspects of prevention, treatment, as well as molecular aspects and pathophysiology. Translational research focused on the exchange of ideas between clinicians and researchers is also welcome. Journal of Diabetes Investigation is indexed by Science Citation Index Expanded (SCIE).